ClinicalTrials.govpublic full text
Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
lymphoma, stage ii mycosis fungoides/sezary syndrome, stage iv mycosis fungoides/sezary syndrome, recurrent mycosis fungoides/sezary syndrome, stage iv cutaneous t-cell non-hodgkin lymphoma, stage ii cutaneous t-cell non-hodgkin lymphoma, recurrent cutaneous t-cell non-hodgkin lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 806764
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.